Biological Aging Accelerated With Breast Cancer Diagnosis, Treatment
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, July 25, 2023 -- Breast cancer diagnosis and treatment is associated with accelerated biological aging, according to a study published online July 19 in the Journal of the National Cancer Institute.
Jacob K. Kresovich, Ph.D., from the H. Lee Moffitt Cancer Center & Research Institute in Tampa, Florida, and colleagues generated DNA methylation data on paired blood samples collected an average of 7.7 years apart among 417 women enrolled in the prospective Sister Study cohort. Data were used to calculate three epigenetic metrics of biological aging. Overall, 190 of the women sampled were diagnosed and treated for breast cancer between blood draws (diagnoses occurred an average of 3.5 years after the initial blood draw) and 227 remained free of breast cancer.
The researchers found that compared with women who remained cancer-free, those diagnosed and treated for breast cancer had higher biological aging at the second blood draw as measured by all three metrics and after accounting for covariates and biological aging metrics measured at baseline. Radiation had a strong positive association with biological aging in case-only analyses assessing associations with different breast cancer therapies.
"Radiation is a valuable treatment option for breast cancer, and we don't yet know why it was most strongly associated with biological age," a coauthor said in a statement. "This finding supports efforts to minimize radiation exposures when possible and to find ways to mitigate adverse health effects among the approximately 4 million breast cancer survivors living in the United States."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Donepezil Not Beneficial for Cognitive Impairment in Breast Cancer Survivors
FRIDAY, May 24, 2024 -- A once-daily dose of donepezil does not improve cognitive function among breast cancer survivors exposed to chemotherapy one to five years earlier...
ASCO: Survivors of Early Breast Cancer Can Successfully Attempt Pregnancy
THURSDAY, May 23, 2024 -- Most survivors of stage 0 to III breast cancer who attempt pregnancy postdiagnosis are able to become pregnant and have a live birth, according to a...
4-Dimensional Model Can Predict Lymph Node Metastases in Breast Cancer
THURSDAY, May 23, 2024 -- A deep learning model using tumor dynamic contrast-enhanced breast magnetic resonance imaging (MRI) has high sensitivity for identifying lymph node...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.